TotalMarketCap

Lisata Therapeutics

LSTANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.804 M

$1.00 -5.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Lisata Therapeutics (LSTA) has a market capitalization of $10.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$170.0K

#3553 by revenue

Earnings

-$17.0M

Loss-making

Shares outstanding

9,010,937

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #408VyomeHIND$11.3M
  2. #409Cellectar BiosciencesCLRB$11.0M
  3. #410Lisata TherapeuticsLSTA$10.8M
  4. #411Palatin TechnologiesPTN$10.5M
  5. #412BiovieBIVI$10.5M

What if Lisata Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,613,541

Per share 2,613,541× higher

Bitcoin $1.53T

$141,414.17

Per share 141,414× higher

Apple $5.02T

$464,249.54

Per share 464,250× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Lisata Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.